IONS
Ionis Pharmaceuticals Inc
43.90$
-4.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -11.5% | -9.8% | -11.0% | -15.3% | -14.9% | 98.0% | 72.3% | 35.9% | 56.6% | 51.6% | 38.9% | 18.8% | 35.6% | 39.3% | 32.7% | 14.6% | 155.3% | 125.0% | 112.9% | 113.6% | 99.3% | 72.9% | 0.3% | 0.4% | 1.6% | 1.3% | 2.4% | 1.2% | 1.6% | 1.7% | |
| 111.5% | 109.8% | 111.0% | 115.3% | 114.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 165.1% | 119.3% | 100.0% | 100.0% | 100.0% | 100.0% | -55.3% | -25.0% | -12.9% | -13.6% | 0.7% | 100.0% | 99.7% | 99.6% | 98.4% | 98.7% | 97.6% | 98.8% | 98.4% | 98.3% | |
| 201.3% | 170.9% | 158.7% | 195.9% | 153.0% | 157.2% | 154.7% | 234.0% | 278.0% | 205.5% | 542.2% | 158.8% | 99.3% | 110.7% | 133.8% | 158.8% | 155.3% | 125.0% | 112.9% | 113.6% | 99.3% | 72.9% | 69.1% | 41.5% | 73.4% | 79.3% | 141.8% | 114.2% | 127.9% | 97.0% | |
| – | – | – | – | 101.0% | 20.8% | 10.7% | 18.6% | 22.5% | 21.0% | 84.9% | 27.3% | 12.9% | 11.9% | 10.8% | 12.9% | 12.3% | 10.1% | 9.4% | 13.1% | 14.0% | 21.1% | 40.8% | 25.6% | 48.6% | 21.1% | 25.6% | 29.5% | 37.9% | 41.7% | |
| 239.6% | 205.5% | 193.9% | 242.5% | 192.7% | 186.5% | 163.4% | 258.0% | 376.5% | 242.5% | 538.9% | 156.4% | 112.2% | 122.6% | 144.6% | 171.8% | 12.3% | 135.1% | 9.4% | 13.1% | 113.4% | 94.0% | 109.9% | 67.1% | 121.9% | 102.4% | 167.4% | 143.8% | 165.8% | 138.8% | |
| -128.2% | -95.7% | -82.9% | -127.1% | -77.8% | -86.5% | -63.4% | -158.0% | -276.5% | -142.5% | -438.9% | -56.4% | -12.2% | -22.6% | -44.6% | -71.8% | -67.5% | -35.1% | -22.3% | -26.7% | -13.4% | 6.0% | -10.2% | 32.6% | -23.6% | -3.7% | -69.8% | -44.9% | -67.4% | -40.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 28.6% | 20.7% | 37.4% | 53.0% | 50.6% | 60.8% | 13.0% | 5.2% | 10.4% | 12.2% | 16.9% | 20.7% | 13.1% | 10.4% | 12.9% | 11.2% | 8.7% | 7.5% | 4.4% | 6.2% | 1.2% | 1.4% | 10.3% | 12.8% | 9.6% | |
| -111.5% | -83.8% | -85.5% | -148.4% | -125.8% | -138.6% | -90.1% | -190.0% | -334.3% | -180.4% | -439.6% | -18.8% | -13.5% | -26.1% | -56.4% | -85.6% | -73.1% | -45.2% | -25.4% | -31.0% | -24.1% | -3.3% | -12.7% | 30.9% | -23.3% | -3.6% | -43.9% | -42.4% | -65.2% | -40.3% | |
| -12.3% | -1.2% | 26.8% | 47.5% | 65.7% | 16.7% | 8.5% | 35.6% | 133.9% | 55.3% | -153.1% | -47.9% | -1.0% | 2.6% | 0.1% | 0.0% | -8.9% | -4.0% | -7.2% | 0.1% | 0.8% | -1.2% | -48.5% | 3.9% | 43.5% | -0.1% | 2.0% | 4.1% | -0.9% | 0.1% | |
| -116.7% | -95.1% | -109.7% | -174.6% | -143.6% | -138.6% | -90.1% | -190.0% | -334.3% | -180.4% | -308.9% | -18.8% | -17.0% | 127.5% | -56.5% | -85.6% | -64.2% | -41.2% | -18.2% | -31.1% | -25.0% | 0.1% | 45.6% | 26.2% | -66.8% | -3.5% | -45.9% | -46.5% | -64.4% | -40.4% | |
| -116.7% | -85.9% | -71.9% | -111.8% | -63.0% | -73.5% | -49.9% | -129.9% | -171.9% | -99.3% | -394.0% | -44.8% | 3.8% | -13.3% | -35.7% | -56.8% | -41.8% | -28.4% | -10.6% | -14.4% | -10.8% | 7.1% | -3.1% | 34.0% | -21.2% | -0.6% | -38.8% | -29.9% | -50.2% | -30.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.